Discussion On The Combining Testing Of Serum Levels Of M₂-PK, CA125, CYFRA21-1, NSE, TSGF For The Clinical Value In Lung Carcinoma Diagnosis

Background and ObjectiveIn recent years, both the incidence and mortality of primary lung cancer have been on the rise, with its mortality rate ranking first of all cancer deaths. Therefore, it is of great significance to improve the diagnostic and treatment levels of lung cancer. Serum tumor marker(TM) is one of the major research topics of modern oncology, while the serum detection of lung cancer has become an important target for the diagnosis of the alignancy. Single TM would not be satisfactory in sensitivity and specificirty, and shows its limitations in the diagnosis of lung cancer. Thus, for the lung cancer patients, we have conducted to combine detection of the tumor M2 Pyruvate kinase (TU M2-PK), Carbohydrate antigen 125 (CA125), Cytokeratin fragment antigen 21-1 ( CYFRA21-1), neuron-specific enolase(NSE), Tumor supplied group of factor (TSGF) in the diagnosis of this mortal disease,the aim of this study is to evaluate the role of the combined detection in the diagnosis of lung cancer.